SEARCH

SEARCH BY CITATION

References

  • AkerstromB, BorregaardN, FlowerDR, SalierJ-P (eds) (2006) Lipocalins. Georgetown, TX: Landes Biosciences.
  • Akerstrom B, Maghzal G, Winterbourn CC, Kettle AJ (2007) The lipocalin alpha 1-microglobulin has radical scavenger activity. J. Biol. Chem. 282, 3149331503.
  • Allhorn M, Berggard T, Nordberg J, Olsson ML, Akerstrom B (2002) Processing of the lipocalin alpha (1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99, 18941901.
  • Allhorn M, Klapyta A, Akerstrom B (2005) Redox properties of the lipocalin alpha1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron. Free Radic Biol. Med. 38, 557567.
  • Balboa MA, Balsinde J (2006) Oxidative stress and arachidonic acid mobilization. Biochim. Biophys. Acta 1761, 385391.
  • Barnes CA (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp Physiol. Psychol. 93, 74104.
  • Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol. Med. 32, 797803.
  • Blanco-Vaca F, Via DP, Yang CY, Massey JB, Pownall HJ (1992) Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J. Lipid Res. 33, 17851796.
  • Breustedt DA, Schonfeld DL, Skerra A (2006) Comparative ligand-binding analysis of ten human lipocalins. Biochim. Biophys. Acta 1764, 161173.
  • Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC (1997) Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol. Med. 23, 361366.
  • Crawley J (2000) What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. New York: Wiley-Liss.
  • Eichinger A, Nasreen A, Kim HJ, Skerra A (2007) Structural insight into the dual ligand specificity and mode of high density lipoprotein association of apolipoprotein D. J. Biol. Chem. 282, 3106831075.
  • Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917921.
  • Flower DR, North ACT, Sansom CE (2000) The lipocalin protein family: structural and sequence overview. Biochim. Biophys. Acta 1482, 924.
  • Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell. 10, 10331043.
  • Hulbert AJ (2005) On the importance of fatty acid composition of membranes for aging. J. Theor. Biol. 234, 277288.
  • Lechner M, Wojnar P, Redl B (2001) Human tear lipocalin acts as an oxidative-stress-induced scavenger of potentially harmful lipid peroxidation products in a cell culture system. Biochem. J. 356, 129135.
  • McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, Di Monte DA (2005) Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93, 10301037.
  • Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L, Milne R (2000) Apolipoprotein D. Biochim. Biophys. Acta. 1482, 185198.
  • Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ, Ganfornina MD, Walker DW, Muffat J, Rundel C, Benzer S (2006) Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr. Biol. 16, 680686.
  • Sato N, Fujii K, Yuge O, Morio M (1992) Changes in lipid peroxidation levels and lipid composition in the lungs, livers, kidneys and brains of mice treated with paraquat. J. Appl. Toxicol. 12, 365368.
  • Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 92079214.
  • Thomas EA, Yao JK (2006) Clozapine specifically alters the arachidonic acid pathway in mice lacking apolipoprotein D. Schizophr. Res. 89, 147153.
  • Thomas EA, Dean B, Pavey G, Sutcliffe JG (2001) Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders. Proc. Natl Acad. Sci. USA 98, 40664071.
  • Thomas EA, Copolov DL, Sutcliffe JG (2003a) From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr. Mol. Med. 3, 408418.
  • Thomas EA, George RC, Sutcliffe JG (2003b) Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot Essent Fatty Acids. 69, 421427.
  • Tomita M, Okuyama T, Katsuyama H, Hidaka K, Otsuki T, Ishikawa T (2006a) Gene expression in rat lungs during early response to paraquat-induced oxidative stress. Int. J. Mol. Med. 17, 3744.
  • Tomita M, Okuyama T, Katsuyama H, Ishikawa T (2006b) Paraquat-induced gene expression in rat kidney. Arch. Toxicol. 80, 687693.
  • Vajragupta O, Monthakantirat O, Wongkrajang Y, Watanabe H, Peungvicha P (2000) Chroman amide 12P inhibition of lipid peroxidation and protection against learning and memory impairment. Life Sci. 67, 17251734.
  • Van Dijk W, Do Carmo S, Rassart E, Dalhlback B, Sodetz J (2006) The plasma Lipocalins α1-acid glycoprotein, apolipoprotein D, apolipoprotein M and complement C8γ. In Lipocalins. (AkerstromB, BorregaardN, FlowerD, SalierJ, eds). Georgetown, TX: Landes Bioscience, pp. 140166.
  • Walker DW, Muffat J, Rundel C, Benzer S (2006) Overexpression of a Drosophila homolog of apolipoprotein D leads to increased stress resistance and extended lifespan. Curr. Biol. 16, 674679.